Cystadenocarcinoma Endometrioid

Cystadenocarcinoma Endometrioid: Description, Diagnosis and Treatment

Endometrioid cystadenocarcinoma (c. endometrioideum) is a rare type of ovarian cancer that usually develops in women between the ages of 30 and 60 years. This type of cancer is one of the most aggressive and fastest spreading types of ovarian cancer. Cystadenocarcinoma endometrioid can also occur in other organs such as the uterus, oviducts, and abdomen.

Diagnosis of endometrioid cystadenocarcinoma can be difficult because its symptoms can be nonspecific and similar to those of other diseases. Often the only way to determine the presence of this cancer is a biopsy, which removes a tissue sample for further testing.

Treatment for endometrioid cystadenocarcinoma may include surgical removal of the tumor, chemotherapy, and radiation therapy. Depending on the stage of cancer and its spread

Cystadenoid endomitriotic carcinoma (CEC), also known as endometrial adenocarcinoma, is a type of cancer that arises from the epithelial cells lining the inside of the uterus, as well as from the tissues that surround this area. It is a rare condition that occurs mainly in women over 50 years of age, but can also occur in younger women.

Risk factors

The development of CCE is associated with a wide range of factors, including heredity, smoking, obesity, diabetes and certain medications. The most common causes of the development of this tumor are hormonal disorders and the presence of endometriosis, a disease in which uterine tissue grows outside its cavity. The risk of developing CCE increases in women suffering from endometa